MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN)

270 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q1 2016.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 81,837,318 shares of 93,104,451 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (11,367,036 shares), Capital Research Global Investors (8,620,839 shares), SCOPIA CAPITAL MANAGEMENT LP (5,403,662 shares), VANGUARD GROUP INC (5,074,985 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (4,508,349 shares), D. E. Shaw & Co., Inc. (2,928,144 shares), BlackRock Fund Advisors (2,730,915 shares), STATE STREET CORP (2,200,112 shares), RS INVESTMENT MANAGEMENT CO LLC (2,178,740 shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (2,093,457 shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.